A periodic table for cancer

Future Oncology
Richard J Epstein

Abstract

Cancers exhibit differences in metastatic behavior and drug sensitivity that correlate with certain tumor-specific variables such as differentiation grade, growth rate/extent and molecular regulatory aberrations. In practice, patient management is based on the past results of clinical trials adjusted for these biomarkers. Here, it is proposed that treatment strategies could be fine-tuned upfront simply by quantifying tumorigenic spatial (cell growth) and temporal (genetic stability) control losses, as predicted by genetic defects of cell-cycle-regulatory gatekeeper and genome-stabilizing caretaker tumor suppressor genes, respectively. These differential quantifications of tumor dysfunction may in turn be used to create a tumor-specific 'periodic table' that guides rational formulation of survival-enhancing anticancer treatment strategies.

References

Nov 22, 1991·Science·R A Weinberg
Dec 15, 1993·Journal of the National Cancer Institute·M F PouponT Le Chevalier
Dec 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A G Knudson
Apr 24, 1997·Nature·K W Kinzler, B Vogelstein
Mar 31, 1998·Oncogene·B LiJ M Rosen
May 20, 1998·Isis; an International Review Devoted to the History of Science and Its Cultural Influences·A G Debus
Jun 2, 1998·Molecular and Cellular Endocrinology·C ScuriniV Colantuoni
Feb 15, 2001·Molecular Aspects of Medicine·J S Bertram
Apr 13, 2001·Journal of Combinatorial Chemistry·T I Oprea, J Gottfries
Jan 5, 2002·Acta Oncologica·A I Robles, C C Harris
Apr 3, 2002·Trends in Molecular Medicine·Nicola C Levitt, Ian D Hickson
Apr 12, 2002·Nature·William R Taylor
Mar 6, 2003·Human Mutation·Milena GascoTim Crook
Apr 18, 2003·Frontiers in Bioscience : a Journal and Virtual Library·Guo-Min Li
Jun 11, 2003·Annals of the New York Academy of Sciences·V N Ostrovsky
Mar 10, 1962·Lancet·D W SMITHERS
Jan 30, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S FerlicotX Sastre-Garau
Mar 3, 2004·Nature Reviews. Cancer·P Andrew FutrealMichael R Stratton
Apr 6, 2004·Lancet·David Sharp
Jun 8, 2004·Carcinogenesis·Brandt L Schneider, Molly Kulesz-Martin
Aug 3, 2004·Nature Medicine·Bert Vogelstein, Kenneth W Kinzler
Jul 21, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jeffrey N WeitzelSusan Neuhausen
Mar 24, 2006·The British Journal of Surgery·K SöreideJ P A Baak
Mar 28, 2006·Breast Cancer Research : BCR·Eitan FriedmanUNKNOWN Hereditary Breast Cancer Clinical Study Group
Jul 20, 2006·DNA and Cell Biology·Kazuhiro IshikawaToshiyuki Saito
Jul 22, 2006·Trends in Genetics : TIG·Floyd A Reed, Charles F Aquadro
Aug 4, 2006·Cancer Research·Sam Thiagalingam
Nov 17, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jason H BielasLawrence A Loeb
Feb 7, 2007·Brain Research·Mia ThompsonCynthia Shannon Weickert
Apr 14, 2007·Molecular Cancer Therapeutics·Fadi Braiteh, Razelle Kurzrock
Jun 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gizeh Pérez-TenorioOlle Stål
Dec 7, 2007·Nature Reviews. Cancer·Robert A Gatenby, Robert J Gillies
Jun 7, 2008·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Ralf J Sommer

❮ Previous
Next ❯

Citations

Jun 14, 2020·Signal Transduction and Targeted Therapy·Ling ChenYongguang Tao

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsies
exome sequencing
environmental stress
genotyping

Related Concepts